Work

Dose Intensity in Real-World Patients With Metastatic Renal Cell Carcinoma Taking Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors

Year: 2023

Type: article

Study design: Observational Study

Source: Clinical Genitourinary Cancer

DOI: 10.1016/j.clgc.2023.02.007

Authors: Hartlee Johnston, Allison M. Deal, Katherine P. Morgan, Bianka Patel, Matthew I. Milowsky, Tracy L. Rose

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Selective histone deacetylase inhibition with entinostat to enhance the anti-tumor immune response to immune checkpoint inhibition in urothelial cancer, Short Term Research Training

OpenAlex ID: W4321113278

FWCI: 1.1

Cites: 19

Cited by: 6

Related to: 10